Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06326905

CAPABLE Transplant

The purpose of this mixed methods study is to adapt CAPABLE as CAPABLE Transplant to accomplish two things: 1) To resolve barriers to being classified as active on the Kidney Transplant (KT) waitlist, 2) as a surgical prehabilitation intervention targeting the pre-frail/ frail KT waitlist population. It consists of two phases- an open label pilot and a randomized waitlist control trial, and 3) pilot test the feasibility and acceptability for CAPABLE Transplant in symptom and waitlist specific metrics amongst low-income active kidney transplant waitlist candidates.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Johns Hopkins School of Nursing

Baltimore, Maryland, 21205, United States

Location status: Recruiting

Location contact

Meagan Clemence, MS

CONTACT

[email protected]

410-705-5808

About this study

CAPABLE is a multicomponent goal-directed program that reduces physical disability by working with the person and environment but has not been explored in prehabilitation research. The purpose of this study is to adapt CAPABLE, an existing evidence-based program for functionally and socio-economically vulnerable older adults, as a prehabilitation intervention for people with frailty awaiting KT.

As in CAPABLE, the delivery characteristics of CAPABLE Kidney Transplant consist of an assessment-driven, individually tailored package of interventions delivered over the course of 4 months by an occupational therapist (OT) (~6 home visits for ≤ 1hour), a registered nurse (RN) (~4 home visits for ≤ 1hour) and a handy worker (HW).

In earlier phases, research team members conducted preliminary activities to design the CAPABLE Kidney Transplant intervention using Human-Centered Design techniques.

This study will seek to accomplish two aims:

  • To iteratively refine the CAPABLE -Transplant prototype for those currently KT inactive or those who are active and low-income on the waitlist.
  • To pilot test the CAPABLE-Transplant intervention

The investigators will collect feedback during the open label pilot to further refine the intervention that will be tested as part of the randomized control trial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Deceased Donor Waitlist
  • ≥18 years old
  • Community dwelling
  • Current Inactive status or active and had been inactive in the last 18 months for cardiovascular disease, frailty, obesity, social support, mental health, incomplete testing OR Active on the waitlist and low-income

Exclusion criteria

  • Living Donor Waitlist
  • Severe cognitive impairment
  • Inactivity expected to last > 3 months (eg cancer treatment)
  • >4 hospitalizations in the last 12 months
  • Current home nursing, physical or occupational therapy

Treatment and study plan

CAPABLE Transplant- Open Label Pilot

Behavioral

As in CAPABLE, the delivery characteristics of CAPABLE Transplant consist of an assessment-driven, individually tailored package of interventions delivered over the course of 4 months by an occupational therapist (OT) (~6 home visits for ≤ 1hour), a registered nurse (RN) (~4 home visits for ≤ 1hour) and a handy worker (HW).

Adaptations targeting those currently KT inactive will be made on a per-client basis as part of the open-label pilot. We will further refine and develop the intervention by receiving feedback from the open label pilot participants and CAPABLE clinicians who implemented the pilot to gain their perspective of the acceptability and feasibility of implementing the CAPABLE-Transplant intervention. Based on this feedback, the study team will have developed an adapted iteration of the prototype.

CAPABLE Transplant- Randomized Control Trial

Behavioral

As in CAPABLE, the delivery characteristics of CAPABLE Transplant consist of an assessment-driven, individually tailored package of interventions delivered over the course of 4 months by an occupational therapist (OT) (~6 home visits for ≤ 1hour), a registered nurse (RN) (~4 home visits for ≤ 1hour) and a handy worker (HW). Refinements based on the open label pilot results will be included.

Primary outcomes

  1. Waitlist-status as assessed by data obtained by the National Kidney Registry

    Time frame: 0, 16 weeks, 32 weeks

    Death (any cause), Time Inactive

    Change of waitlist status (inactive to active, delisting)

Secondary outcomes

  1. Change in self-efficacy as assessed by the Coping Self-Efficacy Instrument

    Time frame: Baseline, 16 weeks, 32 weeks

    Coping Self-Efficacy is a 13 item instrument on a scale of 0 ('can't do at all') to 10 ('certain can do'). A higher score indicates higher level of self-efficacy when implementing coping strategies. Score range 0-130.

  2. Change in self-efficacy as assessed by the Self-Efficacy of Chronic Disease Management Instrument

    Time frame: Baseline, 16 weeks, 32 weeks

    Self-Efficacy of Chronic Disease Management Instrument is a 6 item instrument on a visual analog scale, ranging from 1 (not at all confident) to 10 (totally confident). Lower scores indicate lower self-efficacy as indicated by confidence. Score range 6-60.

  3. Change in Pain as assessed by the Brief Pain Inventory

    Time frame: Baseline, 16 weeks, 32 weeks

    The Brief Pain Inventory - is a 4-item self-administered questionnaire used to evaluate the severity of a patient's pain and the impact of this pain on the patient's daily functioning. The patient is asked to rate their worst, least, average, and current pain intensity, list current treatments and their perceived effectiveness, and rate the degree that pain interferes with general activity, mood, walking ability, normal work, relations with other persons, sleep, and enjoyment of life on a 10 point scale. For the 10 point scale, 0 indicated no pain and 10 indicates the worst imaginable pain. Score range 0-40.

  4. Change in Depression as assessed by the Patient Health Questionnaire Depression Scale (PHQ-8)

    Time frame: Baseline, 16 weeks, 32 weeks

    The PHQ-8 contains 8 questions, with a 0-3 scale. A score of 10 or greater is considered major depression, 20 or more is severe major depression. Score range 0-30.

  5. Change in Social engagement as assessed by the Lubben Social Network Scale

    Time frame: Baseline, 16 weeks, 32 weeks

    The Lubben Social Network Scale is a 7-item questionnaire that measures the size of social networks of family and friends. The score ranges between 0 and 30, with higher scores indicated more social engagement.

  6. Change in Social engagement as assessed by the Krause-Borawski-Clark Support Interactions Scale

    Time frame: Baseline, 16 weeks, 32 weeks

    The Krause-Borawski-Clark Support Interactions Scale is a 10-item self-reported questionnaire that measures social interactions. The scale is broken down into different domains; scores range from very often (4); fairly often (3); once in a while (2); never (1) or binary-- satisfied (1) or not satisfied (0) depending on domain within the questionnaire. Items are summed to form a single composite score range 10-40, Higher scores on the scale is associated with better personal perception and social support.

  7. Change in Fatigue/Quality of Life as assessed by the Kidney disease Quality of Life Scale

    Time frame: Baseline, 16 weeks, 32 weeks

    The Kidney disease Quality of Life Short Form is a 20-item self-report outcome measure for patients on dialysis. Higher scores indicate better health-related quality of life. Scores range from 0-100.

  8. Change in Frailty as assessed by the Fried Frailty Phenotype

    Time frame: Baseline, 16 weeks, 32 weeks

    The Fried Frailty Phenotype contains 5 criteria: unintentional weight loss >10lbs >5% of body mass in the last year, weakness (handgrip strength measurement), exhaustion (based on the Center for Epidemiological Studies Depression Scale), slow gait (walking time over a distance), and low physical activity. People who had none of the criteria were considered non-frail, people who had 1 and 2 criteria were considered pre-frail, and people who had ≥3 criteria were considered frail.

  9. Change in Health Team Communication as assessed by the CollaboRATE Scale Measure

    Time frame: Baseline, 16 weeks, 32 weeks

    The CollaboRATE scale measure is a 3 item self-report questionnaire on patient's shared decision making. It is scored on a 10-point anchored scale, ranging from 0 ("no effort was made") to 9 ("every effort was made"). Higher scores indicate more shared decision making.

  10. Change in Function as assessed by Lawton & Brody's assessment of Instrumental Activities of Daily Living Scale

    Time frame: Baseline, 16 weeks, 32 weeks

    The assessment contains 8 questions with answers that are either a score of 0 or 1. A summary score ranges from 0 (low function, dependent) to 8 (high function, independent) for women, and 0 through 5 for men to avoid potential gender bias.

  11. Change in Function as assessed by the Katz Index of Independence in Activities of Daily Living

    Time frame: Baseline, 16 weeks, 32 weeks

    6 questions, each 1 point for a total score of 6. A score closer to 6 indicates high patient independence.

Other outcomes

  1. Acceptability at endpoint of intervention assessed by survey

    Time frame: 16 weeks

    Score on Likert scale-based questions re: program content & structure satisfaction, willingness to recommend. Survey developed by study team.

  2. Feasibility as assessed by qualitative questions

    Time frame: 16 weeks

    Open/ Close Ended Questions, Recruitment Rate, Completion Rate, Data Collection Rate, Mean time for survey administration, Withdrawal Rate, Cost. Questions developed by study team.

  3. Fidelity as assessed by percent completion of intervention items

    Time frame: 16 weeks

    % tasks/ patient- directed content delivery per session for Nurse & Occupational Therapist, % completion of home modifications

Study contacts

Contact information is provided by the study sponsor or research team.

Meagan Clemence, MS

CONTACT

[email protected]

410-705-5808

Melissa Hladek, PhD

CONTACT

[email protected]

4106142418

Sponsors and collaborators

Lead sponsor

Johns Hopkins University

Other

Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registry information

Official study title

Addressing Inactive Kidney Transplant Waitlist Status Through Adapting a Tailored Psycho-Social-Environmental Program

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Mar 22, 2024
Registry last updated
Jul 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.